Advances in the treatment of KPC-producing Klebsiella pneumoniae infec-tion / 中国感染控制杂志
Chinese Journal of Infection Control
; (4): 250-256, 2024.
Article
ي Zh
| WPRIM
| ID: wpr-1024112
المكتبة المسؤولة:
WPRO
ABSTRACT
In recent years,the isolation rate of carbapenem-resistant Klebsiella pneunoniae(CRKP)in China has increased year by year.Due to its multidrug resistance and high mortality in patients,CRKP brings severe challen-ges to the clinical treatment.The major mechanism of drug resistance in CRKP is the production of carbapenemases,with Ambler A,B,and D being the common types while Ambler type C comparativly rare.Klebsiella pneumoniae carbapenemase(KPC)is the most common carbapenemase,which belongs to type A.KPC-producing Klebsiella pneumoniae(KPC-KP)widely spreads in the world,with very limited number of effective clinical drugs.In this re-view,advances in the treatment KPC-KP were summarized to provide reference for clinical treatment.
النص الكامل:
1
الفهرس:
WPRIM
اللغة:
Zh
مجلة:
Chinese Journal of Infection Control
السنة:
2024
نوع:
Article